Today: 29 April 2026
Browse Category

TSX:7013 5 September 2025 - 5 January 2026

Tokyo stocks today: Nikkei starts 2026 higher as TEPCO, chip and defense names lead

Tokyo stocks today: Nikkei starts 2026 higher as TEPCO, chip and defense names lead

Japan’s Nikkei 225 surged 3.03% to 51,865 in its first 2026 session, led by a 9.23% jump in TEPCO after it announced plans to restart a reactor this month. Chip and defense stocks rallied, while the yen weakened to 157.295 per dollar. S&P Global’s December manufacturing PMI held at 50.0. Investors now await the BOJ’s Jan. 22-23 meeting and U.S. jobs data due Jan. 9.
5 January 2026
········
Asia Markets Rollercoaster: Nikkei Smashes Records as Hang Seng Rebounds – Fed Jitters and Tech Rally Whipsaw Stocks

Asia Markets Rollercoaster: Nikkei Smashes Records as Hang Seng Rebounds – Fed Jitters and Tech Rally Whipsaw Stocks

Japan’s Nikkei 225 closed at a record 45,630 on September 24, driven by AI and chip stocks. Hong Kong’s Hang Seng fell 0.7% Tuesday on typhoon fears, then rebounded 1.37% Wednesday as tech shares rallied. Shanghai’s Composite rose 0.83% and Shenzhen’s index jumped 1.8% on semiconductor gains. South Korea’s KOSPI hit a record, then retreated as foreign investors sold and the won weakened.
24 September 2025
····
Japan’s Space and Satellite Industry: A Comprehensive 2025 Market Report

Japan’s Space and Satellite Industry: A Comprehensive 2025 Market Report

Japan became the fifth country to land on the Moon in 2024 with JAXA’s SLIM probe. The nation’s space industry is valued at ¥4 trillion ($26 billion), with plans to double by the early 2030s. Over 50 startups now operate in the sector, up from about 10 a few years ago. The government aims to boost annual launches from five in 2024 to 30 by the 2030s.
5 September 2025
·········

Stock Market Today

  • Sensex Rallies 609 Points as Nifty Nears 24,200 on Strong Earnings and Geopolitical Hope
    April 29, 2026, 9:39 AM EDT. Indian benchmark indices rebounded Wednesday with the BSE Sensex rising 609 points (0.79%) to 77,496.36 and the NSE Nifty climbing 182 points (0.76%) to 24,177.65. Gains were broad-based, led by FMCG, auto, and telecom stocks. Maruti Suzuki surged nearly 3% following a record annual net profit, lifted by highest-ever sales and GST rate cuts. Positive earnings reports and easing geopolitical tensions fueled investor sentiment despite elevated crude oil prices which rose 2.85% to $114.4 a barrel. Asian markets also closed higher, reflecting a global mood shift. However, European and U.S. markets remained subdued. Analysts noted improved corporate performance and hopes of reduced global conflicts helped offset macroeconomic concerns and contributed to today's rebound.

Latest article

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

29 April 2026
Cambridge, Massachusetts, April 29, 2026, 09:04 EDT Biogen Inc. cut its full-year profit outlook on Wednesday, taking some shine off a first-quarter earnings beat driven by stronger sales of its Alzheimer’s drug Leqembi and newer rare-disease medicines. The Cambridge, Massachusetts-based drugmaker now expects 2026 adjusted earnings of $14.25 to $15.25 a share, down $1 at both ends of its prior range. Biogen said the cut reflects acquired in-process research and development charges, meaning costs tied to buying or licensing drug programs that are still being developed and have not yet become commercial products. (marketscreener.com) The revision matters because Biogen is
Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Go toTop